Article
Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 1 Oct 2017
Yi Xingyang, Wang Yanfen, Lin Jing, Cheng Wen, Zhou Qiang, Wang Chun
Abstract excerpt
OBJECTIVE: Clopidogrel is a clinically important oral antiplatelet agent for the treatment or prevention of cerebrovascular disease. However, different individuals have different sensitivities to clopidogrel. This study assessed variants of different genes for association with response to clopidogrel, clinical outcome, and side effects in patients with ischemic stroke (IS). METHODS: We consecutively enrolled 375...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
